Former Stryker Medical Division president Brad Saar joins Sonablate Board to support growth of non-invasive prostate cancer treatment.

{
  "signal_id": "5104ac55-5a99-4265-bd8e-9fb9f460587f",
  "signal_type": "news",
  "signal_subtype": "leaves",
  "detected_at": "2026-04-30T00:00:00+00:00",
  "company": {
    "name": "Stryker",
    "domain": "stryker.com"
  },
  "data": {
    "url": "https://www.globenewswire.com/news-release/2026/04/30/3284955/0/en/former-stryker-medical-division-president-brad-saar-joins-sonablate-board-to-support-growth-of-non-invasive-prostate-cancer-treatment.html",
    "title": "Former Stryker Medical Division president Brad Saar joins Sonablate Board to support growth of non-invasive prostate cancer treatment.",
    "contact": "Brad Saar",
    "excerpt": "Former Stryker Medical Division president Brad Saar joins Sonablate Board to support growth of non-invasive prostate cancer treatment.\n\nAppointment signals next phase of expansion for hifu-based prostate care as demand grows for non-invasive, function-preserving treatment options.\n\nApril 30, 2026 09:03 ET | Source: Sonablate\n\nCHARLOTTE, N.C., April 30, 2026 (GLOBE NEWSWIRE) - Sonablate, a medical technology company focused on non-invasive prostate cancer treatment using high-intensity focused ultrasound (HIFU), today announced the appointment of Brad Saar, former president of Stryker's Medical Division, to its Board of Directors. Saar's addition reflects Sonablate's continued focus on expanding adoption of HIFU and advancing its \"precision sound medicine\" platform - an approach that uses targeted ultrasound energy to treat disease with surgical-level precision while preserving patient function.\n\n\"With experienced leadership and growing clinical interest, we are well positioned to scale globally, expand physician education, and advance precision sound...\"\n\n\"What's compelling is that prostate cancer treatment is reaching an inflection point where non-invasive, targeted approaches are moving beyond early adoption...\"\n\n\"Having spent my career scaling global medical technology businesses, I see meaningful potential for HIFU and focal therapy to expand within standard care...\"\n\n\"We...",
    "summary": "Brad Saar leaves Stryker as Board of Directors.",
    "category": "leaves",
    "found_at": "2026-04-30T00:00:00Z",
    "planning": false,
    "image_url": "https://ml.globenewswire.com/Resource/Download/dc6636f6-7b53-461a-9684-b8391c5ca4b0",
    "job_title": "Board of Directors",
    "confidence": 0.5036,
    "assets_tags": [
      "education"
    ],
    "published_at": "2026-04-30T13:03:00Z",
    "job_title_tags": [
      "education",
      "directors"
    ],
    "article_sentence": "CHARLOTTE, N.C., April 30, 2026 (GLOBE NEWSWIRE) - Sonablate, a medical technology company focused on non-invasive prostate cancer treatment using high-intensity focused ultrasound (HIFU), today announced the appointment of Brad Saar, former president of Stryker's Medical Division, to its Board of Directors."
  }
}

curl https://signals.autobound.ai/v1/signals/5104ac55-5a99-4265-bd8e-9fb9f460587f \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"stryker.com","limit":20}'